Articles tagged "Pancreas"

2021 American Transplant Congress
Achilles Heel No Longer: Marked Decline in Early Relaparotomy and Allograft Pancreatectomy Rates Following Simultaneous Kidney-Pancreas Transplantation in the Contemporary Era
B. Sharda¹, K. Gurung², R. Stratta², A. Farney², G. Orlando², C. Jay², A. Reeves-Daniel³, A. Mena-Gutierrez³, N. Sakhovskaya³, W. Doares⁴, S. Kaczmorski⁴, M. Magid⁴, J. Rogers²
¹Wake Forest Baptist Medical Center, Winston Salem, NC, ²Department of Surgery, Wake Forest Baptist Medical Center, Winston-Salem, NC, ³Internal Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC, ⁴Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: Technical complications requiring early relaparotomy (relap) and allograft pancreatectomy (AP) have long been the Achilles heel of simultaneous kidney-pancreas transplantation (SKPT).*Methods: Single center retrospective…
2021 American Transplant Congress
One-Year Monitoring of Changes to Kidney-Pancreas Waiting Time Criteria: An OPTN Analysis
R. C. Forbes¹, B. Plucinski², J. White², N. T. Kyaw², R. Kandaswamy³, S. V. Niederhaus⁴
¹Surgery, Vanderbilt University, Nashville, TN, ²UNOS, Richmond, VA, ³Surgery, University of Minnesota, Minneapolis, MN, ⁴Surgery, University of Maryland, Baltimore, MD
*Purpose: In 2018, the OPTN board approved changes to kidney-pancreas (KP) waiting time criteria. KP candidates accrued waiting time if they were (1) on insulin…
2021 American Transplant Congress
The Implementation of the New Unos Policy That Relegates C-peptide and Body Mass Index Criteria Has Resulted in Shifting Recipient Demographics
R. Teo, A. Rechnitzer, N. A. Muhdi, J. Torabi, M. Ajaimy, L. Liriano-Ward, Y. Azzi, C. Pynadath, P. Loarte-Campos, A. Brooks, J. P. Rocca, M. Le, E. Akalin, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Waitlist time accrual for SPK was previously limited to candidates on insulin that had either a c-peptide ≤ 2 ng/ml, or a c-peptide >…
2020 American Transplant Congress
AIPCs Home to and Engraft in the Pancreas When Injected Intravenously
J. B. Pollett¹, N. Thai²
¹Imagine Pharma, Pittsburgh, PA, ²Allegheny Health Network, Pittsburgh, PA
*Purpose: AIPCs (Activated Islet Proliferating Cells) are a recently developed cell population generated from isolated islets of mice and humans. AIPCs are over 65% CD133-,…
2020 American Transplant Congress
Implications for Facilitated Pancreas Transplant Allocation with the Removal of Donor Service Area
R. Forbes¹, R. Urban², A. Fox², J. Odorico³, S. Niederhaus⁴
¹Vanderbilt University Medical Center, Nashville, TN, ²United Network for Organ Sharing, Richmond, VA, ³University of Wisconsin, Madison, WI, ⁴University of Maryland, Baltimore, MD
*Purpose: Facilitated Pancreas (FP) Allocation, modified in August 2016 to be metric-based rather than opt-in, defines an eligible center as one that has transplanted at…
2020 American Transplant Congress
Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study
R. P. Meier, H. Noguchi, Y. Kelly, M. Sarwal, G. Conti, R. Halleluyan, M. Tavakol, P. Stock, C. Freise
Transplant Surgery, University of California San Francisco, San Francisco, CA
*Purpose: Sarcopenia has been identified as a recognized predictive variable for surgical outcomes. We hypothesized that sarcopenia could be a key measure to identify frail…
2020 American Transplant Congress
Lower Extremity Vascular Complications after Simultaneous Pancreas Kidney Transplant
H. J. Braun, D. Amara, T. Sorrentino, J. L. Ramirez, J. Lin, A. Mello, P. G. Stock, J. S. Hiramoto
University of California, San Francisco, San Francisco, CA
*Purpose: Type 1 diabetes mellitus (DM) is the leading indication for simultaneous pancreas kidney transplantation (SPK). Prior work has demonstrated a 2% incidence of lower…
2020 American Transplant Congress
Early Tacrolimus-LCP Conversion Due to Adverse Effects in Pancreas Transplant Recipients Improves Tolerance But Not Graft Survival
J. L. Descourouez, M. R. Jorgenson, D. C. Felix, J. Wiegel, G. E. Leverson, D. A. Mandelbrot, R. R. Redfield, J. S. Odorico
UW Health, Madison, WI
*Purpose: Tacrolimus-LCP (LCPT) is an extended release formulation of tacrolimus which has been shown to have fewer adverse drug effects (ADE) than immediate release tacrolimus…
2020 American Transplant Congress
Outcomes of Simultaneous Pancreas-Kidney vs. Kidney Alone Transplants in Type 2 Diabetic Recipients: A Multivariate Analysis of U.S. Transplants
S. M. Riad¹, S. Jackson², D. Keys¹, V. Humphereville³, L. Caramori¹, R. Kandaswamy³
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The impact of simultaneous pancreas-kidney (SPK) transplants in uremic, non-obese, insulin-treated type 2 diabetic (T2DM) recipients is not well described. We analyzed the SRTR…
2020 American Transplant Congress
Management of Pancreatic Cancer after Liver Transplantation: A 27-Year Single-Center Experience
I. A. Ziogas, M. A. Rauf, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. P. Alexopoulos
Vanderbilt University Medical Center, Nashville, TN
*Purpose: The occurrence of de novo cancer after liver transplant (LT) is a leading cause of post-LT mortality and can be partially attributed to the…

1
2
3
…
8
Next Page »